Magnesium for acute stroke (Intravenous Magnesium Efficacy in Stroke trial): randomised controlled trial.
D000208:Acute Disease; D000368:Aged; D016001:Confidence Intervals; D005260:Female; D006801:Humans; D007262:Infusions, Intravenous; D016015:Logistic Models; D008278:Magnesium Sulfate / Q000008:administration & dosage / Q000627:therapeutic use*; D008297:Male; D018696:Neuroprotective Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D016017:Odds Ratio; D010919:Placebos; D011446:Prospective Studies; D020521:Stroke / Q000188:drug therapy* / Q000401:mortality / Q000503:physiopathology; D016019:Survival Analysis; D016896:Treatment Outcome
D018696:Neuroprotective Agents; D010919:Placebos; D008278:Magnesium Sulfate